Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells

Journal of Cell Science

Volumn 126, Issue 13, 2013, Pages 2890-2902

  Stöckl, Sabine ^a   Bauer, Richard J ^a   Bosserhoff, Anja K ^a   Göttl, Claudia ^a   Grifka, Joachim ^a   Grässel, Susanne ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adipogenic differentiation; Adult msc; Cell cycle; Proliferation; Signalling; Sox9

Indexed keywords

BAG 1 PROTEIN; CASPASE 3; CASPASE 7; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; OSTEOCALCIN; PROTEIN BCL 2; PROTEIN P21; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR SOX9;

ADIPOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; UPREGULATION; WESTERN BLOTTING;

ADIPOGENIC DIFFERENTIATION; ADULT MSC; CELL CYCLE; PROLIFERATION; SIGNALLING; SOX9;

ADIPOGENESIS; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN D1; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MESENCHYMAL STROMAL CELLS; OSTEOCALCIN; OSTEOGENESIS; P21-ACTIVATED KINASES; PRIMARY CELL CULTURE; RATS; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR;

EID: 84880688991     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.124305     Document Type: Article

References (71)

1. Ahmed, N., Vogel, B., Rohde, E., Strunk, D., Grifka, J., Schulz, M. B. and Grässel,S. (2006). CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells. Int. J. Mol. Med. 18, 233-240.
2. Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. and de Crombrugghe, B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression ofSox5 and Sox6. Genes Dev. 16, 2813-2828.
3. Akiyama, H., Lyons, J. P., Mori-Akiyama, Y., Yang, X., Zhang, R., Zhang, Z.,Deng, J. M., Taketo, M. M., Nakamura, T., Behringer, R. R. et al. (2004). Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18, 1072-1087.
4. Akiyama, H., Kim, J. E., Nakashima, K., Balmes, G., Iwai, N., Deng, J. M., Zhang, Z., Martin, J. F., Behringer, R. R., Nakamura, T. et al. (2005). Osteo- chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl. Acad. Sci. USA 102, 14665-14670.
5. Ambrosino, C., Iwata, T., Scafoglio, C., Mallardo, M., Klein, R. and Nebreda, A. R. (2006). TEF-1 and C/EBPbeta are major p38alpha MAPK-regulated transcription factors in proliferating cardiomyocytes. Biochem. J. 396, 163-172.
6. Aouadi, M., Bost, F., Caron, L., Laurent, K., Le Marchand Brustel, Y. and Binetruy, B. (2006a). p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 24,1399-1406.
7. Aouadi, M., Laurent, K., Prot, M., Le Marchand-Brustel, Y., Binetruy, B. and Bost, F. (2006b). Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55, 281-289.
8. Asada, M., Yamada, T., Ichijo, H., Delia, D., Miyazono, K., Fukumuro, K. and Mizutani, S. (1999). Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1)in monocytic differentiation. EMBO J. 18, 1223-1234.
9. Atadja, P., Wong, H., Veillete, C. and Riabowol, K. (1995). Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell Res. 217, 205-216.
10. Awad, M. M., Enslen, H., Boylan, J. M., Davis, R. J. and Gruppuso, P. A. (2000). Growth regulation via p38 mitogen-activated protein kinase in developing liver. J. Biol. Chem. 275, 38716-38721.
11. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M. and Draetta, G. (1993). Cyclin D1is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
12. Bastide, P., Darido, C., Pannequin, J., Kist, R., Robine, S., Marty-Double, C., Bibeau, F., Scherer, G., Joubert, D., Hollande, F. et al. (2007). Sox9 regulates cellproliferation and is required for Paneth cell differentiation in the intestinal epithelium. J. Cell Biol. 178, 635-648.
13. Bi, W., Huang, W., Whitworth, D. J., Deng, J. M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B. (2001). Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. USA 98, 6698-6703.
14. Boland, G. M., Perkins, G., Hall, D. J. and Tuan, R. S. (2004). Wnt 3a promotesproliferation and suppresses osteogenic differentiation of adult human mesenchymalstem cells. J. Cell. Biochem. 93, 1210-1230.
15. Boudreau, N., Werb, Z. and Bissell, M. J. (1996). Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawalfrom the cell cycle. Proc. Natl. Acad. Sci. USA 93, 3509-3513.
16. Buck, I., Morceau, F., Cristofanon, S., Heintz, C., Chateauvieux, S., Reuter, S., Dicato, M. and Diederich, M. (2008). Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Biochem. Pharmacol. 76, 1229-1239.
17. Casanovas, O., Miró, F., Estanyol, J. M., Itarte, E., Agell, N. and Bachs, O. (2000). Osmotic stress regulates the stability ofcyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275, 35091-35097.
18. Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M. and Sherr, C. J. (1999). The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
19. Conrad, P. W., Rust, R. T., Han, J., Millhorn, D. E. and Beitner-Johnson, D. (1999).Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J. Biol. Chem. 274, 23570-23576.
20. Cuadrado, A. and Nebreda, A. R. (2010). Mechanisms and functions of p38 MAPKsignalling. Biochem. J. 429, 403-417.
21. Dean, J. L., Sully, G., Clark, A. R. and Saklatvala, J. (2004). The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediatedmRNA stabilisation. Cell. Signal. 16, 1113-1121.
22. Dexheimer, V., Frank, S. and Richter, W. (2012). Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. Stem Cells Dev. 21 , 2160-2169.
23. Diehl, J. A., Cheng, M., Roussel, M. F. and Sherr, C. J. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev.12, 3499-3511.
24. Dulić, V., Stein, G. H., Far, D. F. and Reed, S. I. (1998). Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18, 546-557.
25. Duttaroy, A., Qian, J. F., Smith, J. S. and Wang, E. (1997). Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J. Cell. Biochem. 64, 434-446.
26. Engelman, J. A., Lisanti, M. P. and Scherer, P. E. (1998). Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J. Biol. Chem. 273, 32111-32120.
27. Foster, J. W., Dominguez-Steglich, M. A., Guioli, S., Kwok, C., Weller, P. A.,Stevanović, M., Weissenbach, J., Mansour, S., Young, I. D., Goodfellow, P. N.et al. (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 'ill, 525-530.
28. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I. and Frolova, G. P. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247.
29. Fu, M., Wang, C., Li, Z., Sakamaki, T. and Pestell, R. G. (2004). Minireview: CyclinD1: normal and abnormal functions. Endocrinology 145, 5439-5447.
30. Guo, Y. L. and Yang, B. (2006). Altered cell adhesion and cell viability in a p38alpha mitogen-activated protein kinase-deficient mouse embryonic stem cell line. StemCells Dev. 15, 655-664.
31. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. (1993). Thep21 Cdk-interacting protein Cip1 is a potentinhibitorofG1 cyclin-dependentkinases. Cell 75, 805-816.
32. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E. et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
33. Horie, R., Ishida, T., Maruyama-Nagai, M., Ito, K., Watanabe, M., Yoneyama, A., Higashihara, M., Kimura, S. and Watanabe, T. (2007). TRAF activation of C/EBPbeta (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/ macrophages. Microbes Infect. 9, 721-728.
34. Jiang, S. S., Fang, W. T., Hou, Y. H., Huang, S. F., Yen, B. L., Chang, J. L., Li,S. M., Liu, H. P., Liu, Y. L., Huang, C. T. et al. (2010). Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin. Cancer Res. 16, 4363-4373.
35. Kirsch, D. G., Doseff, A., Chau, B. N., Lim, D. S., de Souza-Pinto, N. C., Hansford, R., Kastan, M. B., Lazebnik, Y. A. and Hardwick, J. M. (1999). Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 274, 21155-21161.
36. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A. and Harlow, E. (1997). New functional activities for the p21family of CDK inhibitors. Genes Dev. 11, 847-862.
37. Lamb, J. and Ewen, M. E. (2003). Cyclin D1 and molecular chaperones: implicationsfor tumorigenesis. Cell Cycle 2, 525-527.
38. Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R. and Ewen, M. E. (2003). Amechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334.
39. Lavoie, J. N., L'Allemain, G., Brunet, A., Miiller, R. and Pouyssegur, J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616.
40. Lefebvre, V. and de Crombrugghe, B. (1998). Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol. 16, 529-540.
41. Lefebvre, V., Li, P. and de Crombrugghe, B. (1998). A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17, 5718-5733.
42. Lefebvre, V., Behringer, R. R. and de Crombrugghe, B. (2001). L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway.Osteoarthritis. Cartilage. 9 Suppl. A, S69-S75.
43. Li, B., Si, J. and DeWille, J. W. (2008). Ultraviolet radiation (UVR) activates p38 MAPkinase and induces post-transcriptional stabilization of the C/EBPdelta mRNA in G0 growth arrested mammary epithelial cells. J. Cell. Biochem. 103, 1657-1669.
44. Li, J., Zhao, Z., Liu, J., Huang, N., Long, D., Wang, J., Li, X. and Liu, Y. (2010). MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway. Cell Prolif. 43, 333-343.
45. Longobardi, L., O'Rear, L., Aakula, S., Johnstone, B., Shimer, K., Chytil, A., Horton, W. A., Moses, H. L. and Spagnoli, A. (2006). Effect of IGF-I in thechondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J. Bone Miner. Res. 21, 626-636.
46. Matheu, A., Collado, M., Wise, C., Manterola, L., Cekaite, L., Tye, A. J., Canamero, M., Bujanda, L., Schedl, A., Cheah, K. S. et al. (2012). Oncogenicity of thedevelopmental transcription factor Sox9. Cancer Res. 72, 1301-1315.
47. Matsushime, H., Roussel, M. F., Ashmun, R. A. and Sherr, C. J. (1991). Colony-stimulating factor 1 regulates novel cyclins during the G1 phase ofthe cell cycle. Cell 65, 701-713.
48. Oh, C. D., Chang, S. H., Yoon, Y. M., Lee, S. J., Lee, Y. S., Kang, S. S. and Chun, J. S. (2000). Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation ofchondrogenesis ofmesenchymes. J. Biol. Chem. 275, 5613-5619.
49. Pal, R., Janz, M., Galson, D. L., Gries, M., Li, S., Johrens, K., Anagnostopoulos, I., Dorken, B., Mapara, M. Y., Borghesi, L. et al. (2009). C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells. Blood 114, 3890-3898.
50. Panda, D. K., Miao, D., Lefebvre, V., Hendy, G. N. and Goltzman, D. (2001). Thetranscription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J. Biol. Chem. 276, 41229-41236.
51. Passeron, T., Valencia, J. C., Namiki, T., Vieira, W. D., Passeron, H., Miyamura, Y. and Hearing, V. J. (2009). Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J. Clin. Invest. 119, 954-963.
52. Perlman, H., Zhang, X., Chen, M. W., Walsh, K. and Buttyan, R. (1999). Anelevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cellapoptosis. Cell Death Differ. 6, 48-54.
53. Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J. and Arnold,A. (1999). The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20, 501-534.
54. Ranta, F., Leveringhaus, J., Theilig, D., Schulz-Raffelt, G., Hennige, A. M., Hildebrand, D. G., Handrick, R., Jendrossek, V., Bosch, F., Schulze-Osthoff,K. et al. (2011). Protein kinase C delta (PKC8) affects proliferation of insulin-secreting cells by promoting nuclear extrusion of the cell cycle inhibitor p21Cip1/WAF1. PLoS ONE 6, e28828.
55. Shi, G., Sohn, K. C., Li, Z., Choi, D. K., Park, Y. M., Kim, J. H., Fan, Y. M., Nam,Y. H., Kim, S., Im, M. et al. (2013). Expression and functional role ofSox9 in human epidermal keratinocytes. PLoS ONE 8, e54355.
56. Song, L., Webb, N. E., Song, Y. and Tuan, R. S. (2006). Identification and functionalanalysis of candidate genes regulating mesenchymal stem cell self-renewal andmultipotency. Stem Cells 24, 1707-1718.
57. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J. A. and Reed, J. C. (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-bindingprotein with anti-cell death activity. Cell 80, 279-284.
58. Tare, R. S., Townsend, P. A., Packham, G. K., Inglis, S. and Oreffo, R. O. (2008).Bcl-2-associated athanogene-1 (BAG-1): a transcriptional regulator mediating chondrocyte survival and differentiation during endochondral ossification. Bone 42,113-128.
59. Tew, S. R. and Hardingham, T. E. (2006). Regulation of SOX9 mRNA in humanarticular chondrocytes involving p38 MAPK activation and mRNA stabilization. J. Biol. Chem. 281, 39471-39479.
60. Tsuda, M., Takahashi, S., Takahashi, Y. and Asahara, H. (2003). Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J. Biol. Chem. 278, 27224-27229.
61. Tuan, R. S., Boland, G. and Tuli, R. (2003). Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res. Ther. 5, 32-45.
62. Vincent, A. J., Ren, S., Harris, L. G., Devine, D. J., Samant, R. S., Fodstad, O. and Shevde, L. A. (2012). Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. FEBS Lett. 586, 3429-3434.
63. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E. et al. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related geneSOX9. Cell 79, 1111-1120.
64. Wang, X. Z. and Ron, D. (1996). Stress-induced phosphorylation and activation of thetranscription factor CHOP (GADD153) by p38 MAP Kinase. Science 272, 1347-1349.
65. Wang, Y. and Sul, H. S. (2009). Pref-1 regulates mesenchymal cell commitment anddifferentiation through Sox9. Cell Metab. 9, 287-302.
66. Wright, E. M., Snopek, B. and Koopman, P. (1993). Seven new members of the Sox gene family expressed during mouse development. Nucleic Acids Res. 21, 744.
67. Yagi, R., McBurney, D. and Horton, W. E., Jr (2005). Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2signaling pathway. J. Biol. Chem. 280, 30517-30525.
68. Yang, K., Hitomi, M. and Stacey, D. W. (2006). Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div. 1, 32.
69. Yeh, W. C., Cao, Z., Classon, M. and McKnight, S. L. (1995). Cascade regulation ofterminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9, 168-181.
70. Zhang, R., Murakami, S., Coustry, F., Wang, Y. and de Crombrugghe, B. (2006). Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. Proc. Natl. Acad. Sci. USA 103, 365-370.
71. Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M. H. and Hung, M. C. (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3, 245-252.